Lexicon Pharmaceuticals, Inc.
LXRX
$1.74
$0.042.35%
Headlines
5/5/2024
-
Seeking Alpha: Transcripts
5/5/2024
-
SeekingAlpha
5/4/2024
-
Ticker Report
5/4/2024
-
Zolmax
5/3/2024
-
Ticker Report
5/3/2024
-
TipRanks Financial Blog
5/3/2024
-
GuruFocus
5/3/2024
-
GuruFocus
5/3/2024
-
InvestorPlace
5/2/2024
-
Zacks Investment Research
5/2/2024
-
GuruFocus
5/2/2024
-
Globe Newswire
5/2/2024
-
Ticker Report
5/2/2024
-
Ticker Report
Lexicon Pharmaceuticals, Inc. Forecasted to Earn Q1 2024 Earnings of ($0.13) Per Share (NASDAQ:LXRX)
5/2/2024
-
Ticker Report
4/30/2024
-
Ticker Report
4/29/2024
-
SeekingAlpha.com: All News
4/29/2024
-
Globe Newswire
4/29/2024
-
Globe Newswire
4/27/2024
-
Ticker Report
4/25/2024
-
Zolmax
4/23/2024
-
TipRanks Financial Blog
4/22/2024
-
Seeking Alpha - Healthcare
4/19/2024
-
Ticker Report
4/18/2024
-
Globe Newswire
Filings
Monday, March 25, 2024
Sunday, December 31, 2023
Beginning of May (est)
Price History
Corporate Info
281 863 3000
2445 Technology Forest Boulevard
The Woodlands, TX 77381
The Woodlands, TX 77381
Business Description
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug...
more